Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Details

Connection

Mandy Sakamoto to Antibodies, Monoclonal, Humanized

This is a "connection" page, showing publications Mandy Sakamoto has written about Antibodies, Monoclonal, Humanized.

 
Connection Strength
  
 
 
0.123
  
  1. Sakamoto M, Jimeno A. Sugemalimab, a novel PD-L1 inhibitor for treatment of advanced or metastatic non-small cell lung cancer. Drugs Today (Barc). 2023 Mar; 59(3):169-177.
    View in: PubMed
    Score: 0.123
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)